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Laboratory, University of Oxford, Oxford, United KingdomABSTRACT The conversion of human lysozyme into amyloid fibrils is associated with a rare but fatal hereditary form of non-
neuropathic systemic amyloidosis. The accumulation of large amounts of aggregated protein is thought to be initiated by the
formation of transient intermediate species of disease-related lysozyme variants, essentially due to the loss of global coopera-
tivity under physiologically relevant conditions. Interestingly, all five naturally occurring, amyloidogenic, single-point mutations
are located in the b-domain of lysozyme, the region that is predominantly unfolded during the formation of the transient interme-
diate species. Given the lack of known naturally occurring, amyloidogenic, single-point mutations in the a-domain, we chose
three specific mutations to address the effects that location may have on native-state dynamics, as studied by hydrogen-deute-
rium (HD) exchange experiments analyzed by NMR spectroscopy, and mass spectrometry. We compared the effect of a desta-
bilizing a-domain mutation (I23A) with that of the well-characterized I59T b-domain variant. We also investigated the effect of a
mutation that has minor effects on native-state stability at the domain interface (I56V) and compared it with that of a variant with
similar stability within the C-helix (I89V). We show that when variants have similar reduced native-state stabilities, the location of
the mutation (I23A versus I59T) is crucial to the native-state dynamics, with the a-domain mutation having a significantly lower
ability to populate transient intermediate species under physiologically relevant conditions. Interestingly, the mutation at the
interface (I56V) has a greater effect in facilitating the formation of transient intermediate species at elevated temperatures
compared with the variants containing a-domain mutations, even though this mutation results in only minor changes to the
native-state stability of lysozyme. These findings reveal that the location of specific mutations is an important factor in deter-
mining the native-state dynamical properties of human lysozyme in the context of its propensity to populate the aggregation-
prone transient intermediate species associated with pathogenic amyloid formation.INTRODUCTIONHuman lysozyme is a globular protein that acts as a glyco-
sidase and is found in a wide variety of biological fluids (1).
This protein, which is stabilized by four disulphide bonds,
has two structural domains: the a-domain (residues 1–38
and 86–130), which consists of four a-helices, and the
b-domain (residues 39–85), which contains a significant
degree of b-sheet structure (2). Lysozyme has been the sub-
ject of numerous studies related to its structure, function,
folding behavior, and dynamical properties (3). In 1993,
two single-point mutations in human lysozyme (I56T and
D67H) were found to trigger the manifestation of hereditarySubmitted May 19, 2016, and accepted for publication October 19, 2016.
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creativecommons.org/licenses/by/4.0/).nonneuropathic systemic amyloidosis, a rare but fatal
disease (4) that is primarily caused by large amounts of
amyloid deposits accumulating in the liver, kidneys, and
spleen of affected individuals (5,6). Since the discovery of
these variants, other naturally occurring disease-associated
variants (Y54N, F57I, W64R, F57I/T70N, and T70N/
W112R) have been identified, along with two variants
(T70N and W112R) that are not linked to disease (7–11).
A range of studies have investigated the effects of these
disease-associated mutations on the in vitro folding and mis-
folding of lysozyme, as well as on amyloid formation. Rela-
tive to wild-type (WT) human lysozyme, the amyloidogenic
variants I56T and D67H possess reduced native-state stabil-
ities and lower degrees of global structural cooperativity
(12–17). Consequently, they are able to populate transient
intermediate species in vitro under physiologically relevant
Mutational Effects on Lysozyme Dynamicsconditions. In these intermediate species, the b-domain and
the C-helix are cooperatively and significantly unfolded,
whereas the remaining parts of the protein maintain a
native-like structure (13,15,18). The transient intermediate
species can also be detected under similar conditions in
the nonnatural variant, I59T, which has a native-state stabil-
ity lying between that of the I56T variant and WT. Interest-
ingly, the transient intermediate species can be detected in
both the T70N variant and WT, but only under more desta-
bilizing conditions (47C and 57C, respectively) and not
under conditions that are physiologically relevant (19,20).
Previous studies revealed the formation of a transient in-
termediate species as a crucial step in lysozyme aggregation
by examining the binding effects of camelid antibody frag-
ments, often called nanobodies (15,21–23). These studies
identified nanobodies that could bind to the native state of
the lysozyme variants and prevent fibril formation by sup-
pressing the formation of the transient intermediate species
(21,22), or could prevent aggregation at a later stage by
inhibiting the unfolding and structural reorganization of
the a-domain (23). Further studies under strongly acidic
conditions revealed that I56T, I59T, and WT lysozymes
unfold via a cooperative loss of native tertiary structure fol-
lowed by a progressive unfolding of secondary structure,
where the b-domain unfolds followed by the C-helix, the
first two 310 helices, and some residues at the chain termini
(18). Under the same acidic conditions, the relationship
between the population of nonnative conformations and
amyloid formation rates was established: the higher the
population of the ensemble of denatured species, the faster
the rate of amyloid formation (24). It was also shown that
residues within the b-domain and C-helix form the core of
amyloid fibrils when the protein aggregates (25).
Studies of the I56T and D67H proteins have provided
detailed information about the structural effects of these mu-
tations. Overall, the structures of the I56T and D67H vari-
ants, as determined by x-ray crystallography, resemble
that of theWT (12,13). The crystal structure of the I56T pro-
tein is almost identical (RMSDCa < 1 A˚) to that of the WT,
whereas the structure of the D67H protein shows larger
differences (RMSDCa up to 11 A˚) in the residues of the short
(residues 45–51) and long (residues 68–75) loops of the
b-domain, showing that the two loops are significantly per-
turbed from their original positions (13). The prominent
structural changes in the D67H protein are associated with
disruption of one of the two hydrogen-bonding networks
that stabilize the b-domain in the WT (2,13). This destabi-
lizing effect is transmitted to I56, resulting in its side chain
adopting an alternative conformation (13). I56 is located at
the interface between the a- and b-domains, a region that is
crucial for the structural integrity of the protein. Thus, it is
reasonable to conclude that the amyloidogenic nature of
both the I56Tand D67H variants is due to the destabilization
of the interface region between the two domains of lyso-
zyme (13).All of the identified disease-associated single-point muta-
tions are significant amino acid changes found in the
b-domain of lysozyme, either at the domain interface or in
areas with a network of interactions that influences this re-
gion. In this study,we set out to examine how the introduction
of alternativemutations would modify the properties of lyso-
zyme, and for this purpose we selected previously reported,
well-expressed lysozyme variants (I56V and I89V (26),
I23A (27), and I59T (16,19,28)). The I23A variant was cho-
sen because this a-domain mutation affects the native-state
stability of the protein to a similar degree as the well-charac-
terized I59T (b-domain) variant (19), allowing us to directly
compare the effect of a mutation in the a-domain relative to
one in the b-domain. We also chose a mutation that does not
significantly destabilize the native state of lysozyme but is
located in the critical domain interface region, I56V. For
comparison with this variant, we selected the I89Vmutation,
which has a comparable native-state stability and is located in
the C-helix region (Fig. 1 a). We used real-time and pulse-
labeling hydrogen deuterium (HD) exchange experiments,
monitored by NMR and mass spectrometry (MS), respec-
tively, and compared the results with previous findings for
the I56T, I59T, D67H, and T70N variants. The results indi-
cate that the site-specific location of a mutation can signifi-
cantly contribute to altering the native-state dynamics in
variants with mutations that are not greatly destabilizing.
Therefore, in combination, the location of the amyloidogenic
mutation and the reduced native-state stability are key ele-
ments in lysozyme fibril formation.MATERIALS AND METHODS
All chemicals were purchased from Sigma-Aldrich (Gillingham, UK) un-
less otherwise stated.Protein expression and purification
Lysozyme variants were expressed in Pichia pastoris and purified as
described previously (20). Protein purity (>95%) was based on SDS-
PAGE and the molecular masses were confirmed by MS.Thermal denaturation measured by circular
dichroism and fluorescence spectroscopies
Circular dichroism (CD) spectroscopy experiments were performed in a
Jasco J-810 spectropolarimeter (JASCO, Great Dunmow, UK) equipped
with a Peltier temperature controller. The proteins (20 mM) were dissolved
in sodium citrate buffer (10 mM, pH 5) and analyzed in a 0.1 or 1 cm
cuvette. Thermal denaturation was monitored at 222 or 270 nm with tem-
perature increasing from 5C to 95C (0.5C min1). Ellipticity values
were normalized to the fraction of unfolded protein (Fu) using
Fu ¼ ðq qNÞðqU  qNÞ;
where q is the observed ellipticity, and qN and qU are the native- and
unfolded-state ellipticities, respectively. qN and qU were extrapolatedBiophysical Journal 111, 2358–2367, December 6, 2016 2359
FIGURE 1 Human lysozyme mutations dis-
cussed in this study. (a) Mutations in the a-domain
(I23A and I89V) (green), the b-domain (D67H and
T70N) (yellow), and the interface region (I56T,
I56V, and I59T) (red). The location of the
a-domain a-helices (A, B, C, and D), b-strands in
the b-domain (S1, S2, and S3), and 310 helices
(h1, h2, and h3) are shown below the structure,
with magenta lines representing disulphide bonds.
(b) Chemical-shift perturbations in the NMR
spectra (pH 5.0, 37C) of the I23A, I56V, and
I89V variants. Chemical-shift changes are defined
as Dd ¼ ((Dd1H)2 þ (uDd15N)2)0.5, where u ¼
g15N/g1H (19,38), and the threshold for significant
chemical-shift differences was fixed at 0.1 ppm
(19,21). Red arrows indicate the sites of mutation.
Ahn et al.from pre- and posttransition baselines at the relevant temperature. Data
were fitted to a two-state unfolding model (18,29) using OriginPro 8.0
(OriginLab, Northampton, MA). Mid-point Tm values are defined as the
temperatures at which Fu ¼ 0.5. Thermal denaturation monitored by 8-ani-
lino-1-naphthalenesulfonic acid (ANS) fluorescence emission was recorded
on a Cary Eclipse spectrofluorimeter (Agilent, Oxford, UK) using excita-
tion/emission wavelengths of 350 and 475 nm, respectively (slit widths:
5 nm) with increasing temperatures from 20C to 95C (0.5C min1).
Samples contained 2 mM protein (0.1 M sodium citrate pH 5.0, 360 mM
ANS). The transition curves of ANS alone were collected and subtracted
from all samples. The fluorescence data were normalized with respect to
the ANS emission signal in the presence of the I56T variant. Data were
fitted to a Gaussian expression using OriginPro 8.0.Chemical denaturation monitored by intrinsic
fluorescence
The WT, I23A, and I59T proteins were incubated (50 mM sodium phos-
phate pH 6.5, 25C, 18 h) in the presence of increasing guanidinium hy-
drochloride (GdnHCl) concentrations, with protein concentrations of 1.6,
2.1, and 2.1 mM, respectively. The reversibility of the unfolding transitions
was checked by diluting the samples from post-transition (6 M) to pre-tran-
sition GdnHCl concentrations. Unfolding and refolding curves were deter-
mined by monitoring the intrinsic fluorescence emission. Each GdnHCl
concentration was determined by refractometry (30). Fluorescence spectra
were recorded on a LS55 Luminescence spectrometer (Perkin Elmer, Seer
Green, UK) in a 1 cm quartz mini-cell. The spectra were recorded in order
of increasing GdnHCl concentration. Samples were excited at 295 nm,
emission spectra were collected (310–440 nm) with slit widths of 5 nm,
and scans were collected at 60 nm/min (25C, PMT ¼ 900 V). The control
sample spectra were subtracted from the corresponding protein spectra. The
thermodynamic parameters were computed under the assumption of a two-
state model for the unfolding reaction. The corrected fluorescence intensity
at 355 nm was plotted against the GdnHCl concentration in each sample,
and the data were fit as described in (19) to











where S represents the fluorescence signal and [D] represents the GdnHCl
concentration. aN and aU define the intercepts, and bN and bU define the
slopes of the pre- and post-transition regions, respectively. DG(H2O)NU
and m respectively define the difference in free energy between the folded
and unfolded conformations in the absence of denaturant and the depen-2360 Biophysical Journal 111, 2358–2367, December 6, 2016dence of the free energy on the denaturant concentration. The midpoint
of the denaturation curve is given by Cm ¼ DG(H2O)NU/m.In vitro fibril formation
Aggregation studies were performed in triplicate with lysozyme variants
(6.8 mM, 0.1 M sodium citrate buffer, pH 5.0, 62.5 mM thioflavin-T
(ThT)) incubated with stirring at 60C in a Cary Eclipse spectrofluorimeter.
ThT fluorescence was measured with excitation and emission wavelengths
of 440 nm and 480 nm, respectively (slit widths: 5 nm). Samples for trans-
mission electron microscopy were prepared on carbon support film, 400
mesh, 3 mm copper grids (EM Resolutions, Saffron Walden, UK) and
stained with 2% uranyl acetate (w/v). The samples were imaged on an
FEI Tecnai G2 transmission electron microscope (CAIC, University of
Cambridge, Cambridge, UK). Images were analyzed using the SIS Mega-
view II Image Capture system (Olympus, Tokyo, Japan).HD exchange by electrospray ionization MS
EX1 HD exchange of variants was monitored by electrospray ionization
MS (pH 8, 37C or 47C) and the data were processed as previously
described (19,20). Proteins were deuterated at exchangeable sites by dis-
solving lysozyme (0.2 mg) in D2O (pH 3.8, 350 mL), followed by heating
(70C, 10 min) and then cooling to room temperature. The samples were
then lyophilized. Before HD exchange, the samples were dissolved in
D2O (200 mM) and HD exchange was triggered by manual mixing as pre-
viously described (20). Spectra were acquired over a mass/charge range of
500–5000 Da on an LCT MS instrument (Waters, Elstree, UK) equipped
with a nanoflow Z-spray source and calibrated with cesium iodide (15
mM). Data were analyzed using MassLynx 4.0 (Waters) with molecular
masses calculated from the centroid values of at least three charge states.
The mass spectra represent the convolution of three charged species with
minimal smoothing and conversion to a mass scale. The relative intensity
of the intermediate (lower-mass) species to the native-state protein
(higher-mass species) was plotted against the pulse labeling time. The
data were fit to a single exponential curve and the unfolding rate (k) was
calculated. The time constant of the unfolding process is the reciprocal of
the unfolding rate (t ¼ 1/k). All reported t-values are the average of three
to five separate experiments.Real-time HD exchange by NMR
15N-labeled lysozyme variant solutions were prepared in a standard 3 mm
NMR tube (2 mg, 220 mL of 20 mM D-4 acetic acid in D2O (pD 5)), as pre-
viously described (17,20). The samples were immediately placed in a
Mutational Effects on Lysozyme DynamicsBruker Avance 500 MHz NMR spectrometer (Bruker, Coventry, UK), pre-
tuned, and shimmed with an equivalent sample at 37C. A series of hetero-
nuclear single quantum coherence (HSQC) spectra were recorded with two
(first 30 spectra), four (next 30 spectra), and eight (all subsequent spectra)
transients, with 1792 and 96 complex points in t2 and t1, respectively, and
sweep widths of 6010 and 1014 Hz in F2 and F1, respectively. The observed
HD exchange rates (kobs) were measured from peak height reductions over
time by fitting the data to a single exponential decay with or without a con-
stant as a baseline. The predicted rates (kex) for a random coil model based
on the primary structure were calculated by Sphere (http://www.fccc.edu/
research/labs/roder/sphere/) using the pH values of the samples measured
at the end of the experiments. Protection factors (PFs) were calculated
from the ratio of kobs to kex. The ratio of the PF values was calculated by
dividing the PFs of WT by those of each variant.TABLE 1 Tm Values of Lysozyme Variants Measured by
Thermal Denaturation Monitored by Far-UV and Near-UV CD





WT 77.75 0.5a 76.75 0.6b
I89V 77.15 1.0 77.25 0.5
I56V 76.25 0.9 75.35 0.6
T70N 74.05 0.6a 72.25 1.0c
I59T 71.25 0.4a 69.95 0.4b
I23A 69.85 1.0 69.75 1.2
I56T 67.65 0.8a 66.25 1.0b





The I23A, I56V, and I89V mutations do not
significantly alter the lysozyme native-state
solution structure
To understand the effects of the I23A, I56V, and I89V mu-
tations on the native-state structure of lysozyme, we re-
corded HSQC-NMR spectra and compared them with that
obtained for the WT. The spectra for all variants closely
overlaid the WT spectrum, with only minor changes in a
small number of crosspeaks. The backbone amide chemical
shifts were calculated for each variant and confirmed the
absence of major perturbations (Fig. 1 b; Fig. S1 in the Sup-
porting Material). Thus, the global folds of the native-state
structure of the three variants are effectively the same.
Almost all chemical-shift differences (Dd values) be-
tween the I56V or I89V variants and the WT are lower
than the threshold (0.1 ppm), again confirming the structural
similarity between the proteins. There are, however, small
but reproducible differences, including F57 and I89 in the
I56V variant and I56 and I86 in the I89V variant, all of
which are located at the domain interface region (residues
54–59) or in the loop between the first 310 helix (h1) and
the C-helix (residues 86–89), which are in close spatial
proximity to the interface (26). Compared with the I56V
and I89V variants, the I23A protein has a larger number
of affected residues and shows more chemical-shift differ-
ences compared with the WT. The residues that show signif-
icant Dd values are all located near the mutation site in the
a-domain, either sequentially (residues 19–25) or spatially
(residues 98–109) (Fig. 1 b), and are involved in interactions
within the hydrophobic core where residue I23 is located
(26). Interestingly, in the I23A variant, residue I59, located
at the domain interface, also shows significant chemical-
shift perturbations, though this residue is not in close prox-
imity to the mutation site (27). Considering the fact that
I56Vand I89Valso exhibit noticeable chemical-shift pertur-
bations in this region, it appears that the interface region is
sensitive to small structural changes within the protein.
Taken together, the results show that the three mutations
do not significantly alter the overall native-state structure oflysozyme. The slightly higher chemical-shift perturbations
observed in I23A may be explained by a larger cavity in
the hydrophobic core of the a-domain created by the Ile-
to-Ala mutation (27). In the absence of internal water
molecules, the cavity in I23A, which is surrounded by the
B-, C-, and D-helices, is likely to undergo subtle changes
in the microscopic environment and hence generate small
chemical-shift perturbations.The I23A mutation destabilizes the native state of
lysozyme
Here, we assessed the native-state stability of the I23A
variant, as well as the relative stability of all variants, as
compared with the WT using circular dichroism (CD) spec-
troscopy (15,16,19) (Table 1). The resulting data are in
good agreement with the differential scanning calorimetry
experiments reported by Takano et al. (26,27) and Funaha-
shi et al. (28). At pH 5.0, the I89Vand I56V variants show a
native-state stability with comparable Tm values. As previ-
ously reported, the pathogenic variant, I56T, has the lowest
native-state stability, and the stabilities of T70N, a natural,
nonamyloidogenic variant, and I59T, a nonnatural variant,
lie between the native-state stabilities of the I56T variant
and WT.
Unlike I56V and I89V, which do not have large effects on
lysozyme native-state stability, I23A has a significant desta-
bilizing effect, displaying a Tm comparable to that of the
I59T variant, which possesses amyloidogenic characteristics
under physiologically relevant conditions (Fig. 2 a) (19). The
I23A variant shows an increase in ANS fluorescence emis-
sion at temperatures close to its Tm due to the appearance
of partially unfolded intermediates with solvent-exposed hy-
drophobic clusters, and the intensity of the ANS fluorescence
is comparable to that of the I59T variant (Fig. 2 b). GdnHCl-
induced unfolding of the I23Avariant using intrinsic fluores-
cence allowed us to determine that the DG(H2O)NU value
for I23A is 40.6 5 3.4 kJ mol1, which is effectively theBiophysical Journal 111, 2358–2367, December 6, 2016 2361
FIGURE 2 Biophysical characteristics of the
I23A and I59T variants. (a) Thermal denaturation
of I23A (gray circles) and I59T (black triangles)
monitored by far-UV CD (222 nm). (b) Partially
unfolded intermediates observed by ANS fluores-
cence emission. Curves are representative data sets
normalized with respect to the maximum fluores-
cence of the I56T variant (dark gray open squares).
I23A (light gray circles) and I59T (black solid trian-
gles) show similar degrees of ANS signal. The peak
observed for the WT (black open triangles) shows
the lowest intensity. The TmANS values for I56T,
I23A, I59T, and WT are 65.6C 5 0.8C, 72.8C
5 1.3C, 71.0C 5 0.7C, and 79.2C 5 1.4C,
respectively. (c) GdnHCl-induced unfolding of
I23A (light gray circles), I59T (black triangles),
and WT (dark gray open squares) proteins moni-
tored with intrinsic fluorescence measurements.
(d) HD exchange monitored by MS for I23A and
I59T (pH 8, 37C). Initially, the proteins show a
prominent peak corresponding to the deuterated
native protein (higher-mass species) and as time
progresses, a second, lower-mass peak appears,
where deuteron-proton exchange has occurred in
relation to the formation of the transient, partially
unfolded intermediate species. (e) Plot of the time-
dependent increase in the intermediate (lower-
mass) species population of I23A (gray circles)
and I59T (black triangles) at 37C. (f) Aggregation
of lysozyme variants monitored at pH 5.0, 60C,
with stirring shows that I23A (t1/2 ¼ 140 5
50 min) and I59T (t1/2 ¼ 170 5 40 min) formed
ThT-positive fibrils, whereas I56V, I89V, and WT
did not. Inset: transmission electron microscopy im-
ages of the I23A and I59T fibrils (scale bars,
500 nm).
Ahn et al.same as the value obtained for I59T (39.35 3.3 kJ mol1;
Fig. 2 c; Table S1).Lysozyme native-state dynamics are affected by
the location of the mutation
The comparable native-state stabilities of the I23A and I59T
variants provided us an opportunity to compare how muta-
tions in different domains affect the population of the tran-
sient intermediate species relevant to fibril formation. We
monitored HD exchange using MS at pH 8, where the ex-
change is primarily in the EX1 regime due to the high ex-
change rate (kex) relative to the closing rate (kcl), and
which has previously allowed the observation of transient
intermediate states in the I56T and D67H variants
(13,14,17,21). Specifically, we observed bimodal peak dis-
tributions: one representing a population of molecules that2362 Biophysical Journal 111, 2358–2367, December 6, 2016never access the partially unfolded species, and one repre-
senting a population that accesses transiently, at least
once, the intermediate species via locally cooperative un-
folding events. The relative intensities of the lower-mass
species at different times were fitted to a single-exponential
curve to obtain the unfolding rate (k), from which the time
constant of the unfolding process (t ¼ 1/k) could be deter-
mined. It has been shown that the I59T variant populates
the intermediate species under the same physiologically
relevant conditions (37C and pH 8) as do the naturally
occurring amyloidogenic variants, albeit at a slower rate
(t ¼ 30.0 and 212.8 s for I56T and I59T, respectively)
(19). When we compared I23A and I59T, we observed
that, despite the similarity in native-state stability, the
I23Avariant populated the transient, partly unfolded species
with a time constant of unfolding nearly four times larger
than that of I59T (769.2 and 212.8 s, respectively; Fig. 2,
Mutational Effects on Lysozyme Dynamicsd and e; Table 2). This is much larger than the time constant
of unfolding observed under similar conditions for the I56T
and D67H variants (30.0 and 15.3 s, respectively). We
compared the number of protected sites within the higher-
mass and lower-mass peaks for I23A and I59T (Fig. S2),
and found the same degree of protection for both proteins,
confirming that both variants have a similar number of sites
that are not accessible to DH solvent exchange and therefore
are not dramatically different in overall structure. It appears
that the location of the destabilizing mutation plays a role in
how the protein populates the transient intermediate species.
To compare the HD exchange behaviors of the more sta-
ble variants, I56V and I89V, we performed the experiments
at 47C, since at this temperature intermediate species could
be detected for the T70N variant (20). At this elevated tem-
perature, intermediate species were transiently formed for
all variants, with the rate of formation being much faster
than at 37C, and the time constant of unfolding was still
threefold higher for I23A compared with I59T (Table 2;
Fig. 3 a). Interestingly, when we examined the I56V, I89V,
and T70N variants, we found that the ability to populate
the transient intermediate species was greater for the I56V
and T70N proteins, whose time constants of unfolding
were similar to that of I59T under the same conditions,
whereas I89V showed the slowest rate of intermediate for-
mation, with a sixfold larger time constant of unfolding
compared with I59T (Table 2; Fig. 3 b). Although the
I56V and I89V mutations had similar effects on lysozyme
thermostability, the mutation at the interface region had a
more pronounced effect on the global cooperativity of
lysozyme and on the formation of the transient intermediate
species under destabilizing conditions.
The effects of different mutations on the native-state dy-
namics were examined on a residue-specific level using HD
exchange monitored by NMR. At pH 5 and 37C, the ex-
change rate is in the EX2 regime, where the closing rate
(kcl) is much faster than the intrinsic exchange rate (kex)TABLE 2 Time Constants of the Unfolding Process (t ¼ 1/k)
for Variants at 37C and 47C




I89V 77.15 1.0 N/D 66.75 8.9
I56V 76.25 0.9 N/D 13.55 0.5
T70N 74 5 0.6 N/D 8.65 2.0
I59T 71.25 0.4 212.85 4.5 11.65 0.9
I23A 69.85 1.0 769.25 4.5 34.55 6.0
I56T 67.65 0.8 30.05 2.5a N/A
D67H 68.05 1.0b 15.35 0.6b N/A
A bimodal distribution is not detected (N/D) for I89V, I56V, and T70N at
37C. The rates of intermediate formation for I56T and D67H are too
fast to monitor at 47C (under the current experimental setup) and are
not available (N/A).
aData from (19).
bData from (15).and the latter step becomes rate limiting, thereby providing
information about the native-state fluctuations of the protein
(15,17,19,20). HD exchange measurements for the variants
were performed and the ratios of the WT PFs to those of
each variant were determined. A decrease in PFs for the
variant proteins leads to an increase in this ratio, and this
is considered significant when the ratio is higher than 10,
indicating an increase in native-state dynamics (Fig. 4).
Under these conditions, the I56Tand D67H variants show
dramatically reduced PFs relative to the WT, primarily for
the residues in the b-domain and the C-helix (15,17). The
I59T and T70N variants, which are more stable than I56T
and D67H, show smaller decreases in the PFs, particularly
in the b-domain region (19,20). The reduced PFs in the
b-domain of I59T and T70N, as well as the C-helix of
I59T, reveal that they are more accessible to the solvent,
an effect that is attributable to the reductions in global coop-
erativity generated by these mutations. The EX2 exchange
kinetics of the I23A, I56V, and I89V variants were
compared with those of the I59T, T70N, and WT proteins.
The PFs obtained for the WT show the same trend and
values as reported previously (Fig. S3) (17), with residues
involved in secondary-structure elements being highly pro-
tected from exchange except in the 310- and D-helices,
which are highly exposed to the solvent. In I59T, dramatic
decreases in the PFs are observed predominantly in a region
of the b-sheet (residues 50–65), with smaller changes de-
tected in the C-helix (residues 90–100; Fig. 4 a). In contrast,
T70N shows smaller PF ratios than I59T, but in a more
extended region of the b-sheet (residues 38–86; Fig. 4 b).
Interestingly, the I56V variant shows significant differences
in the PF ratios of some residues in the b-sheet region (res-
idues 50–65; Fig. 4 c), although the decreases in the PFs of
I56Vare smaller than those of I59T. Nevertheless, the small
cavity created by the I56V mutation at the domain interface
appears to affect the protein dynamics in a manner similar to
that observed for the amyloidogenic variants. I23A only
shows significant changes in PF ratios in the B-helix and
does not affect residues located in the b-domain or the C-he-
lix (Fig. 4 d). This behavior is clearly very different from
that of the I59T, T70N, and I56V proteins, as well as the
pathogenic variants. Combined with the slower rate of the
unfolding process observed in the EX1 HD exchange exper-
iments, this may suggest possible differences in the mecha-
nism by which I23A is able to populate the transient
intermediate species, or in the structural nature of the inter-
mediate species populated by I23A relative to the I59T
variant. Finally, the HD exchange results for the I89V
variant show no change from the WT (Fig. 4 e).In vitro aggregation of lysozyme variants
Given that we observed significant differences in native-
state dynamics between the I23A and I59T variants, and
also between the I56V and I89V variants, we investigatedBiophysical Journal 111, 2358–2367, December 6, 2016 2363
FIGURE 3 EX1 HD exchange monitored by MS for
lysozyme variants (pH 8, 47C). (a) Time-dependent
increase in the intermediate species population for
I23A (light gray squares) and I59T (black triangles).
(b) Time-dependent increase in the intermediate spe-
cies population for T70N (black circles), I56V (gray
squares), and I89V (light gray circles).
Ahn et al.fibril formation by these variants. Lysozyme is an extremely
stable protein, and numerous aggregation conditions have
been reported, including low pH and high temperatures
(18), high concentrations and low pH (31), and denaturants2364 Biophysical Journal 111, 2358–2367, December 6, 2016at high temperatures (21). For I59T lysozyme, we previ-
ously employed aggregation conditions using a high temper-
ature (60C) at pH 5.0 and with stirring. These conditions
did not result in fibril formation by T70N or WT, but I59TFIGURE 4 (a–e) PFs and WT/variant PF ratios
for (a) I59T, (b) T70N, (c) I56V, (d) I23A, and (e)
I89V measured by NMR (pH 5, 37C). For some
residues, a lack of corresponding PF data for both
the variant and WT leads to an absence of calcu-
lated WT/variant PF ratios.
Mutational Effects on Lysozyme Dynamicsand I56T were found to form fibrils (19). When we exam-
ined the fibril formation of I23A, I59T, I56V, I89V, and
WT at pH 5.0, 60C, over a time course of 900 min, only
I23A and I59T formed mature fibrils, and no significant dif-
ferences in the rates of fibril formation were observed for
these variants despite the differences in their native-state dy-
namics (Fig. 2 f). The relatively harsh aggregation condi-
tions needed to produce in vitro lysozyme fibrils suggest
that the relative rates of aggregation in these conditions
correlate with the native-state stabilities of the proteins.DISCUSSION
Despite their stable natively folded structure under physio-
logical conditions, a range of globular proteins undergo ag-
gregation and cause protein deposition diseases (32,33). In
general, a process of global, or at least partial, unfolding
of the protein is required to initiate aggregation, eventually
giving rise to amyloid formation (34,35). In most cases,
transient and partial unfolding of the protein creates confor-
mational states that are thermodynamically close to the
native state (32). Human lysozyme, consistent with this
behavior, forms transiently populated intermediate states
that appear to be the precursors of the amyloid fibrils asso-
ciated with hereditary, nonneuropathic, systemic amyloid-
osis (13,17,21,36). Extensive studies on human lysozyme
have reported that the pathogenic variants show decreases
in native-state stability and global cooperativity, and
these attributes were linked to an increase in the formation
of partially unfolded, transient intermediate species
(13,15,17). As all of the known natural single-point dis-
ease-associated mutations in lysozyme are in the b-domain
region, we examined the native-state properties and dy-
namics of three nonnatural lysozyme variants with muta-
tions in different locations: an a-domain mutation that
significantly decreases native-state stability, and a mutation
in the interface region and a mutation in the a-domain, both
of which do not result in a large decrease in native-state
stability.
The I23Avariant has a significantly lower thermostability
than the I56Vand I89V variants (Table 1). Indeed, the I23A
variant has a native-state stability similar to that of the I59T
variant (Fig. 2; Table 2) (19). In contrast to the I59T variant,
the EX2 HD exchange pattern of I23A did not show dra-
matic effects of the mutation on the native-state dynamics
within the b-domain and C-helix regions; only slight in-
creases were observed in a small number of residues near
the mutation site. Differences were also evident when the
EX1 HD exchange was monitored by MS, which showed
that although the I23A variant is capable of forming tran-
sient intermediate species under physiologically relevant
conditions, the time constant of unfolding is nearly fourfold
greater than that observed for the I59T variant. This sug-
gests that the location of the mutation can alter how the pro-
tein populates the transient intermediate species, and mayalso cause changes in the structural nature of this species.
When this variant was compared with others at 47C, it
showed a much greater time constant of unfolding compared
with the I59T, T70N, and I56V proteins. Despite its great
importance, the reduced native-state stability of the protein
is not the only determining factor in populating the transient
intermediate state of lysozyme.
The effect of the I56V mutation on the lysozyme native-
state dynamics is very significant, despite the fact that it
shows little difference in native-state stability compared
with the I89V and WT proteins. A comparison of I56V
and I89V in ANS denaturation experiments shows that
I56V displays a higher ANS fluorescence than the I89V
and WT proteins, with a maximum fluorescence similar
to that of the I23A variant (Fig. S4). The I56V variant dis-
plays a trend in local fluctuations similar to that observed
for I59T and other pathogenic lysozymes: the PFs of the
b-sheet residues are greatly decreased, whereas those in
other parts of the protein remain unchanged. Despite this
similar trend, no transient intermediate is observed for
I56V at 37C, although at 47C the I56V variant populates
the transient intermediate species with a time constant of
unfolding similar to that of the I59T and T70N variants
(Table 2), and the I89V variant, although similar in thermo-
stability to I56V, has a much slower rate of intermediate
formation at 47C.
Overall, a comparison of the effects of mutations at three
different locations on lysozyme native-state stability and dy-
namics reveals the importance of the mutations’ location
with regard to population of the transient intermediate spe-
cies. Mutations in the B- or C-helix of the a-domain have a
significantly smaller effect on the ability to populate the in-
termediate species regardless of their overall effect on the
lysozyme native-state stability, whereas even conservative
mutations made in the interface region can alter the local
and global dynamic fluctuations as observed for I56V. As
previously reported, I56 has a crucial role in maintaining
the structural integrity of the protein, linking the two do-
mains of human lysozyme at their interface (13). Hence,
when it is substituted by a polar residue, such as I56T, the
hydroxyl group of threonine in the hydrophobic core of
the protein causes the disruption of intramolecular hydrogen
bonds (12). As a result, the I56T protein significantly loses
global cooperativity and shows a drastic decrease in native-
state stability. Although the Ile-to-Val mutation in I56V is a
more subtle change than Ile-to-Thr, it can still result in sig-
nificant changes to the native dynamics, which may facili-
tate the destabilization and release of the small loop at the
domain interface to the solvent. Interestingly, despite the
fact that the native-state stability of I56V was not greatly
perturbed, at 47C this variant was able to readily populate
the transient, partially unfolded intermediate species that are
critical for lysozyme aggregation. Given the evidence that
the location of point mutations plays a role in whether lyso-
zyme possesses attributes that may facilitate misfolding, itBiophysical Journal 111, 2358–2367, December 6, 2016 2365
Ahn et al.may not be a coincidence that all five natural single-point
mutations greatly affect the small loop region at the domain
interface, either as a result of the mutation being within
this region (Y54N, I56T, and F57I) or through long-range
destabilizing effects transmitted from the long loop in the
b-sheet (W64R and D67H). Although we could not observe
a relationship between the differences in native-state dy-
namics and the propensity to form fibrils, this observation
likely reflects the fact that nonphysiologically relevant con-
ditions were needed to initiate in vitro lysozyme fibril for-
mation. Therefore, it is very possible that the location of
the mutation could be a crucial factor in the propensity for
lysozyme aggregation in patients suffering from systemic
amyloidosis.CONCLUSION
By examining specific mutations (I23A, I56V, and I89V) in
human lysozyme, we found that the location of the muta-
tion influences native-state stability and dynamics, and
the formation of partially unfolded transient intermediate
species in the protein. Even though the I23A variant (a-
domain) has a similarly reduced native-state stability
compared with I59T (b-domain), it results in a significantly
lower ability to populate intermediate species under phys-
iologically relevant conditions. Interestingly, I56V, a muta-
tion that does not greatly perturb lysozyme native-state
stability, has increased native-state dynamics and at
elevated temperatures can readily populate the partially
unfolded transient intermediate species. Furthermore, as
monitored by NMR, the local fluctuations of I56V are
similar to those of I56Tand I59T, whereas the I89V variant,
which is similar in thermostability to I56V, shows no
changes in PFs as compared with the WT. These findings
indicate that mutations in specific regions of lysozyme
can change the native-state dynamics and how the protein
forms partially unfolded intermediate species. In particular,
changes within the interface region appear to be critical,
consistent with previous reports (37) indicating that the
structural integrity of lysozyme hinges on the structure
and dynamics of the interface region between the two
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